Theranos Prosecutors Eye Holmes’s Secret Love as Fodder for Jury
(Bloomberg) -- Prosecutors are angling to dig into Theranos Inc. founder Elizabeth Holmes's clandestine romance with the company's former president when she goes to trial on fraud charges, using the relationship to show that alleged deceptions at the blood-testing startup went well beyond faulty machines.
The alleged concealment of the relationship from investors, directors and employees, as well as from business partners including Walgreens and Safeway, is at the tail end of a list of 22 categories of information that might be used at trial, according to a letter from U.S. prosecutors to defense attorneys.
Holmes, 36, and Sunny Balwani “took steps to hide the existence of this relationship, such as commuting to work separately and avoiding being seen together outside of work,” prosecutors said. “On at least one occasion, when questioned by a journalist as to whether she was in a relationship, Holmes falsely stated that she was not.”
Holmes's lawyers say the government's areas of interest reach “far afield” from the two wire fraud schemes she's charged with and “explodes” the time period from which evidence may be drawn. While the attorneys say they want to avoid delaying a trial set for August, they say the Covid-19 epidemic has only added pressure, making it dangerous if not unlawful for lawyers to interview witnesses and collaborate in person.
“The government's notice carries significant risk of expanding the scope of the trial beyond manageable bounds and impairing the defense's efforts to prepare for trial even if the bulk of the evidence were excluded,” the defense said in a filing.
Read More: Broken Love at Theranos May Be Tested in Criminal Fraud Case
U.S. District Judge Edward Davila in San Jose, California, decided this month that Holmes and Balwani, who were charged together, should face separate trials. The case is closely watched in Silicon Valley where, before it unraveled due to alleged fraud, Theranos attracted the backing of some of the leading venture capital firms and achieved a valuation of $9 billion.
Holmes and Balwani are accused of lying for years, claiming Theranos machines could perform myriad tests with a single drop of blood. Prosecutors alleged they duped investors out of hundreds of millions of dollars, and also defrauded doctors and patients who trusted Theranos test results.
The case is U.S. v. Holmes and Balwani, 18-cr-00258, U.S. District Court, Northern District of California (San Jose).
©2020 Bloomberg L.P.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.